Citigroup Inc Vectiv Bio Holding Ag Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$7.34 - $9.15 $5,886 - $7,338
-802 Reduced 0.99%
80,474 $684,000
Q4 2022

Feb 09, 2023
SELL
$7.79 - $8.98 $2,337 - $2,694
-300 Reduced 0.37%
81,276 $703,000
Q3 2022

Nov 10, 2022
BUY
$4.7 - $6.07 $78,781 - $101,745
16,762 Added 25.86%
81,576 $489,000
Q2 2022

Aug 10, 2022
BUY
$4.2 - $6.55 $272,218 - $424,531
64,814 New
64,814 $350,000

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0
View Full List

About VectivBio Holding AG

VECT Quotes by TradingView
  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email